Exelixis Inc (EXEL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EXEL | AZN | AMGN | GILD | BMY |
| Company | Exelixis Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 49.75 | 188.22 | 340.26 | 131.57 | 59.97 |
| High | 50.33 | 189.08 | 343.80 | 134.52 | 60.25 |
| Low | 49.51 | 186.45 | 338.40 | 131.12 | 59.25 |
| Latest | 50.15 | 187.03 | 339.30 | 134.36 | 59.46 |
| Change | +0.50 | -2.72 | +1.88 | +3.86 | -0.09 |
| % Change | +1.01% | -1.43% | +0.56% | +2.96% | -0.15% |
| Volume | 1,543,900 | 2,120,800 | 1,567,200 | 5,973,600 | 6,489,700 |
| 20-Day Average Volume | 2,800,830 | 2,050,940 | 2,790,080 | 6,239,435 | 10,432,900 |
| Previous Close | 49.65 | 189.75 | 337.42 | 130.50 | 59.55 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 47.70 | 185.00 | 333.37 | 131.75 | 57.56 |
| 20-Day Raw Stochastic | 81.80% | 61.13% | 64.71% | 68.15% | 75.44% |
| 20-Day Relative Strength | 60.08 | 47.51 | 49.40 | 50.02 | 55.46 |
| Weighted Alpha | +26.21 | +27.14 | +20.35 | +21.76 | +28.81 |
| Today's Opinion | 100% Buy | 8% Sell | 8% Sell | 8% Buy | 64% Buy |
| Previous Opinion | 100% Buy | 8% Buy | 8% Sell | 24% Sell | 64% Buy |
| Last Month's Opinion | 88% Buy | 64% Buy | 24% Buy | 24% Buy | 48% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.04% since 05/15/26 | +3.00% since 05/15/26 | +3.98% since 05/15/26 | +3.69% since 05/15/26 | +4.32% since 05/15/26 |
| Low | 48.21 on 05/19/26 | 182.67 on 05/18/26 | 320.96 on 05/19/26 | 128.34 on 05/19/26 | 57.08 on 05/19/26 |
| High | 50.53 on 05/18/26 | 191.50 on 05/21/26 | 343.80 on 05/22/26 | 134.52 on 05/22/26 | 60.25 on 05/22/26 |
| 1-Month | |||||
| %Chg | +7.04% since 04/22/26 | -3.99% since 04/22/26 | -1.91% since 04/22/26 | +1.10% since 04/22/26 | +1.12% since 04/22/26 |
| Low | 43.50 on 05/04/26 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.64 on 04/27/26 | 55.40 on 05/11/26 |
| High | 51.63 on 05/14/26 | 196.64 on 04/23/26 | 350.69 on 04/23/26 | 137.50 on 05/12/26 | 60.78 on 04/30/26 |
| 3-Month | |||||
| %Chg | +14.94% since 02/20/26 | -8.41% since 02/20/26 | -9.46% since 02/20/26 | -11.25% since 02/20/26 | -1.98% since 02/20/26 |
| Low | 39.71 on 03/02/26 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.64 on 04/27/26 | 55.40 on 05/11/26 |
| High | 51.63 on 05/14/26 | 209.93 on 02/27/26 | 391.29 on 03/02/26 | 152.46 on 02/23/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +17.97% since 11/21/25 | +2.76% since 11/21/25 | +0.52% since 11/21/25 | +6.10% since 11/21/25 | +28.56% since 11/21/25 |
| Low | 39.71 on 03/02/26 | 178.08 on 01/21/26 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 47.58 on 11/24/25 |
| High | 51.63 on 05/14/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 12,605,454 | 290,066,304 | 183,115,120 | 166,817,344 | 121,421,536 |
| Shares Outstanding, K | 251,355 | 1,550,908 | 539,685 | 1,241,570 | 2,042,071 |
| Annual Sales | 2,320,130,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | 782,570,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 610,810,000 | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 11,489,000,000 |
| Last Quarter Net Income | 210,470,000 | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 2,677,000,000 |
| 60-Month Beta | 0.38 | 0.26 | 0.44 | 0.31 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.87 on 05/05/26 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 1.58 on 04/30/26 |
| Earnings Date | 07/27/26 | 08/04/26 | 08/04/26 | 08/06/26 | 07/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 16.61 | 20.49 | 15.27 | 15.59 | 10.04 |